This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: Both patients with methamphetamine-associated psychosis (MAP) and patients with schizophrenia suffer from obvious cognitive deficits in working memory, and this affects the functional prognosis of patients. AIM: This study is to investigate the difference of working memory deficits between patients with MAP and patients with schizophrenia, especially the difference of central executive system function, and the relevance of working memory deficits and clinical characteristics. METHODS: Twenty-eight male patients with MAP and twenty-eight patients with schizophrenia were recruited. The working memory of subjects was evaluated with the n-back task edited and adapted from English language materials. The positive syndrome scale of PANSS and CGI were employed to assess psychotic symptoms and the severity of patients. The relevance between working memory deficits and clinical characteristics was low in both the patients with MAP and patients with schizophrenia. CONCLUSION: Patients with MAP were better at regulating, updating, executing and controlling active information than patients with schizophrenia.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Gan et al. (2018) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: